?Anti-diabetic effects of Dorema aucheri
Phase 3
Completed
- Conditions
- Patients with Type II Diabetes.Non-insulin-dependent diabetes mellitus
- Registration Number
- IRCT2014123120502N1
- Lead Sponsor
- Shahid Sadoughi University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
a minimum of 2-year experience with type II diabetes diagnosed by a physician endocrinologist; 40-65 years of age,
Exclusion criteria: free of dietary restrictions/food allergies; not receiving insulin therapy; not using medications or supplementation known to alter sugar/lipid metabolism; no clinical history of cardiovascular, hepatic, gastrointestinal, or renal disease; no recent history of smoking.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Blood levels of glucose. Timepoint: At the baseline of experiment and after 45 days at the end of experiment. Method of measurement: Blood testing.
- Secondary Outcome Measures
Name Time Method The blood level of cholesterol. Timepoint: At the baseline of experiment and after 45 days at the end of experiment. Method of measurement: Blood testing.